STOCK TITAN

F&G Annuities & Life Form 4 shows director restricted stock award

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

F&G Annuities & Life, Inc. (FG) reported an insider equity grant on a Form 4. A director received 6,436 shares of restricted common stock on November 10, 2025 at a stated price of $0, indicating it was an award rather than an open‑market purchase. These restricted shares vest in three equal annual installments beginning November 10, 2026, meaning the director gains full ownership gradually over three years as long as vesting conditions are met. Following this grant, the director beneficially owns 27,310.79 shares of FG common stock directly. This filing reflects routine equity-based compensation used to align director interests with shareholders.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Doka Celina J. Wang

(Last) (First) (Middle)
801 GRAND AVENUE
SUITE 2600

(Street)
DES MOINES IA 50309

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
F&G Annuities & Life, Inc. [ FG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/10/2025 A 6,436(1) A $0 27,310.79 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of restricted common stock vesting in three equal annual installments beginning November 10, 2026.
/s/ Stephanie Jurgens, attorney-in-fact 11/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did F&G Annuities & Life (FG) disclose on this Form 4?

The filing reports that a director of F&G Annuities & Life, Inc. received a grant of 6,436 shares of restricted common stock on November 10, 2025.

At what price were the F&G (FG) restricted shares granted to the director?

The 6,436 restricted shares of F&G common stock were reported as granted at a price of $0, indicating a compensatory equity award rather than a market purchase.

How do the newly granted F&G (FG) restricted shares vest?

The filing states that the restricted common stock vests in three equal annual installments, beginning on November 10, 2026, spreading full ownership over three years.

How many F&G (FG) shares does the director own after this transaction?

After the reported grant, the director is shown as beneficially owning 27,310.79 shares of F&G common stock with direct ownership.

What type of security is involved in this F&G (FG) Form 4 filing?

The transaction involves restricted common stock of F&G Annuities & Life, Inc., which is common equity subject to vesting conditions.

Does this F&G (FG) Form 4 involve any derivative securities?

The provided Table II for derivative securities shows column headers only and no reported derivative security transactions for this filing excerpt.

F&G Annuities & Life Inc

NYSE:FG

FG Rankings

FG Latest News

FG Latest SEC Filings

FG Stock Data

4.25B
131.23M
2.16%
95.95%
0.41%
Insurance - Life
Life Insurance
Link
United States
DES MOINES